Catalyst
Key milestones include interim results on safety and tolerability, as well as any regulatory implications from the study findings.
Date
June 21, 2026
Phase
N/A
Status
watch
Signal score
7.0
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.